Navigation Links
Cequent Names F. Stephen Laroux, Ph.D., Director, Immunology and Inflammatory Diseases
Date:6/2/2009

s well as the role of the immune system in chronic disease. Prior to his tenure at BIDMC, Dr. Laroux conducted research into the immunology of diseases such as IBD, rheumatoid arthritis, ischemia-reperfusion, and myocardial infarction, co-authoring more than 40 publications in peer-reviewed journals. Dr. Laroux received a Ph.D. in molecular and cellular physiology (Chancellor's Award) and a master's degree in human physiology, both from Louisiana State University.

About Cequent Pharmaceuticals, Inc. (www.cequentpharma.com)

An early-stage biopharmaceutical company, Cequent is pioneering the development of novel therapeutics to prevent and treat a wide range of human disorders -- from inflammatory disease to cancer -- based on the company's proprietary technology, TransKingdom RNA interference (tkRNAi). Cequent's first products, now in pre-clinical development, are drug candidates targeting colon-cancer prevention and inflammatory bowel disease. The company designed its powerful tkRNAi technology to deactivate specific disease-causing genes safely and effectively, using non-pathogenic bacteria as an engine to produce and deliver RNAi directly into cells. It is based on ground-breaking scientific research originating at the Institut Pasteur (Paris, France) and at the Beth Israel Deaconess Medical Center/Harvard Medical School. A privately held company based in Cambridge, Massachusetts, Cequent was established in 2006.


'/>"/>
SOURCE Cequent Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cequent Names Ted Hibben Chief Business Officer
2. Two Luminaries Join Cequent Scientific Advisory Board: Judy Lieberman, M.D. Ph.D., and Patrice Courvalin, M.D.
3. Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo
4. Michael D. Taylor, Ph.D., Joins Cequent Pharmaceuticals Board of Directors
5. Lexicon Names Ajay Bansal Executive Vice President and Chief Financial Officer
6. AIAA names top ten emerging aerospace technologies of 2009
7. Microbia, Inc. Names Alex Chu as Vice President of Process Development
8. Premier Research Names Hal Ward, R.Ph., PharmD as Executive Director, Global Pharmacovigilance
9. Pulmonary Hypertension Association Names Dr. Nicholas Hill Recipient of 2009 Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care
10. Orexigen(R) Therapeutics Names Michael Scaife Senior Vice President of Regulatory Affairs and Product Development, Contrave(R) Program
11. Hospira Names Brian Meadows Supply Chain Chief
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... (PRWEB) January 22, 2015 Eckert & ... Mass Spectrometry (AMS) services to the pharmaceutical and biotech ... joined the company in the position of Director of ... of broad and valuable experience in drug metabolism and ...
(Date:1/22/2015)... , Jan. 22, 2015  Transwestern | RBJ today announces the ... office space for Shire a leading biopharmaceutical company, at Two ... | RBJ,s Robert Richards , president, and Brian ... for the entire five-floor building at 95 Hayden Ave. ...
(Date:1/22/2015)... 22, 2015  Transwestern | RBJ today announces the firm brokered ... for Shire a leading biopharmaceutical company, at Two Ledgemont Center ... Robert Richards , president, and Brian Cohen , ... entire five-floor building at 95 Hayden Ave. Photo ...
(Date:1/22/2015)... laboratory information management systems market is a rapidly growing ... due to factors such as rising pressure to comply ... and increasing government support for adoption of HCIT solutions ... the market focus on technological advancements to further the ...
Breaking Biology Technology:Eckert & Ziegler Vitalea Science appoints Mark Seymour, PhD as Director of Science & Technology 2Eckert & Ziegler Vitalea Science appoints Mark Seymour, PhD as Director of Science & Technology 3Transwestern | RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Transwestern?RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 4
... PARIS and KYOTO, Japan, Oct. 25 Cellectis (Alternext: ... for iPS Cells Research and Application (CiRA) of Kyoto ... started a scientific collaboration to combine Cellectis, genome engineering ... to improve the natural characteristics of iPS cells for ...
... PITTSBURGH, Oct. 22 Mylan Inc. (Nasdaq: MYL ... have awarded a collective $1.25 million to support two prominent ... Arts and Sciences of West Virginia and the State of ... Bresch, Mylan,s president and a member of Mylan Charitable Foundation,s ...
... 700 Companies With 1.400 Participants Attend BioSpain 2010 -- MADRID, October 22, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we ...
Cached Biology Technology:Cellectis and the Center for iPS Cells Research and Application Enter Collaboration 2Cellectis and the Center for iPS Cells Research and Application Enter Collaboration 3Mylan and Mylan Charitable Foundation Award a Collective $1.25 Million to Prominent West Virginia Cultural Institutions 2700 Companies With 1.400 Participants Attend BioSpain 2010 2700 Companies With 1.400 Participants Attend BioSpain 2010 3700 Companies With 1.400 Participants Attend BioSpain 2010 4700 Companies With 1.400 Participants Attend BioSpain 2010 5700 Companies With 1.400 Participants Attend BioSpain 2010 6700 Companies With 1.400 Participants Attend BioSpain 2010 7
(Date:12/17/2014)... NEW YORK , Dec. 15, 2014  HITLAB SM ... Practices (GCP) audit to confirm its adherence to current ... enables HITLAB to conduct regulated smart device and smart ... safety and research quality. "HITLAB is determined ...
(Date:12/17/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ) ... Sensor Market 2015-2019" report to their offering. ... major trend upcoming in this market is the increasing ... help in recording of patient data for quick and ...
(Date:12/15/2014)... Dec. 12, 2014 Research and Markets ( ... "Global Facial Recognition Market 2015-2019" report to their ... Facial recognition is a technology used for the ... facial feature of a person such as nose, jaw ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... 23, 2011 Employing technology that reads the entire ... Institute (TGen) and the Technical University of Denmark (DTU) ... Haiti that killed more than 6,000 people and sickened ... the billions of chemical bases in DNA, TGen and ...
... have discovered that bacteria like E. coli and Salmonella have ... to boost their chances for infection. It,s a fascinating ... the Aug. 14 issue of Nature Chemical Biology. ... and their proteins to gain strength. ,The team includes ...
... -- Aug. 22, 2011 -- Researchers at the Joslin Diabetes ... of cells is decreased in the skeletal muscle of those ... of drugs to boost the activity of this enzyme in ... published online today in the Proceedings of the National Academy ...
Cached Biology News:TGen and DTU researchers track source of Haitian cholera outbreak 2TGen and DTU researchers track source of Haitian cholera outbreak 3Newfound hijacked proteins linked to salmonella virulence 2Joslin researchers identify new target for treatment of type 2 diabetes and prediabetes 2